Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment

PURPOSE: The impact of primary tumour radiotherapy on the prognosis for non-small-cell lung cancer (NSCLC) with controlled malignant pleural effusion (MPE-C) (MPE-C-NSCLC) is unclear. This study aimed to analyze the efficacy and safety of primary tumor radiotherapy in patients with MPE-C-NSCLC. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingsong, Hu, Cheng, Su, Shengfa, Ma, Zhu, Geng, Yichao, Hu, Yinxiang, Li, Huiqin, Lu, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716933/
https://www.ncbi.nlm.nih.gov/pubmed/36465711
http://dx.doi.org/10.2147/CMAR.S385818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716933/
https://www.ncbi.nlm.nih.gov/pubmed/36465711
http://dx.doi.org/10.2147/CMAR.S385818

Ejemplares similares